Maike de Wit
Ärztin
Hat mitgewirkt an:
-
Blasenkrebs : eine Leitlinie für Patientinnen und Patienten
-
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
-
Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
-
Palbociclib in acute leukemias with KMT2A-rearrangement: results of AMLSG 23-14 trial